CONMED Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CONMED Corporation (NYSE: CNMD) on June 3, 2026. The report details a material definitive agreement entered into on the same date regarding the company's debt obligations.
Key Financial Metrics and Transaction Details
The filing discloses a specific debt repurchase transaction rather than periodic financial performance metrics such as revenue or operating margins.
- Instrument: 2.25% Convertible Senior Notes due 2027.
- Principal Amount Repurchased: Approximately $645.2 million.
- Cash Consideration: Approximately $637.2 million.
- Expected Closing Date: June 15, 2026, subject to customary conditions.
Material Changes
The primary material change is the reduction of the company's outstanding convertible debt principal by approximately $645.2 million. The transaction involves a cash outflow of approximately $637.2 million, representing a repurchase price slightly below the aggregate principal amount.
Outlook, Risks, and Management Commentary
Management, represented by President and CEO Patrick J. Beyer, has authorized the agreement. The transaction is expected to close on June 15, 2026, contingent upon the satisfaction of customary closing conditions. The filing does not provide updated forward-looking guidance, risk factors, or commentary on unusual items beyond the debt repurchase.
Investor Verification Checklist
- Verify the final closing of the transaction on or around June 15, 2026.
- Confirm the exact final cash outflow and any associated transaction costs.
- Review the impact of this debt reduction on the company's liquidity and leverage ratios in the subsequent quarterly report.
- Check for any remaining outstanding principal on the 2.25% Convertible Senior Notes due 2027.